While domestic market growth is important, the sales trajectory in the international markets, which account for 45 per cent of the revenues, will be a key rerating trigger, say analysts. Ram Prasad Sahu reports. The Godrej Consumer stock was up 4.3 per cent on Friday, leading to expectations of steady growth in the Indian market and improvement in the operating performance of its African unit. In the Indian market, which accounts for over half its revenues, the company expects to maintain double-digit growth on the back of strong demand in rural markets and recovery in urban areas. The soaps category, which reported 15 per cent growth in the December quarter, is expected to rack up similar rates in the March quarter on a weak base, increased consumption, and hygiene awareness. This is aiding sales in the handwash segment. In addition to higher demand, market share gains from smaller players on the back of a differential, region-based pricing strategy should … [Read more...] about Global operations key trigger for Godrej Consumer
IPL 2021 by Cricbuzz Staff • Published on Share Tweet Jaydev Unadkat picked three wickets in the powerplay, triggering Delhi Capitals' batting collapse © BCCI/IPL A stunning, unbeaten 36 from IPL's highest paid player Chris Morris helped Rajasthan Royals get over the line in the final over, chasing 146, and giving them their first win of the tournament. Wait, why did Delhi Capitals get just 146? That was due to the brilliance of Jaydev Unadkat (coming in for Shreyas Gopal) upfront. Having opted to bowl, Unadkat struck thrice in three overs upfront. He was helped adequately by a pitch that was slightly sticky in the initial period. Unadkat was also well supported by the other pacers in the team, who stuck to very specific plans that turned out to be successful for them. What were those plans that downed DC? Mainly it was about taking pace off the ball. Unadkat got the in-form Prithvi Shaw to get a leading … [Read more...] about Unadkat fires Royals to maiden win on return
This article was first published at reviewsfire.com . It contains affiliate links. Please read the disclosure at the end for further details. The Samsung Galaxy Buds Pro are easily Samsung’s best wireless earbuds. They are a significant upgrade on their predecessor the Galaxy Buds Live. However, unless you’re a Samsung Galaxy S21 user, there are better earbuds on the market – the Apple AirPods Pro and the Bose QuietComfort Earbuds, for example). In order to get the best out of the Apple AirPods Pro, you need the latest Apple phone. Similarly, to get the best out of the Buds Pro, you need to have a Samsung Galaxy S21 device. And I would only recommend them if you have that phone. Marquee features like 360 Audio are only available on the Galaxy S21 device and compatibility with Samsung scalable codecs isn’t available for third-party devices. This means that the audio quality isn’t as good on a third-party device and it makes the Buds Pro challenging to recommend for those … [Read more...] about Samsung Galaxy Buds Pro review
This article was first published at reviewsfire.com . It contains affiliate links. Please read the disclosure at the end for further details. The Sony WH-1000XM4 headphones deliver on everything you need in a premium set of headphones. They sound great, they support multiple codecs, they have fantastic active noise cancellation, they’re well-designed and are very comfortable. And you’re getting all of this for a fantastic price. While it’s easy to assume that a cheaper product is an inferior product, this isn’t applicable for the WH-1000XM4. These are premium headphones. I’ve been testing them for a week, and they’re some of the best headphones I’ve ever used. They get everything right. Cheaper than its competitors The Sony WH-1000XM4 headphones cost NZD$400 (USD$349; £349). This is an impressive price point as they are top-of-the-range headphones that are significantly cheaper than other premium headphones on the market. The WH-1000XM4 are cheaper than their main … [Read more...] about Sony WH-1000XM4 review
SINGAPORE - Clinical trials are under way to approve appropriate vaccines for children under 16, the last group in the country to be offered a jab. But while experts note that youngsters are not as likely to transmit the virus and are not a major reservoir of infections, the medical profession said that inoculating this cohort is vital for the community to achieve herd immunity. However, the kind of vaccine that children will receive remains an open question. The Pfizer-BioNTech jab is not recommended for those under 16, while the Moderna vaccine cannot be approved for those under 18 until more safety and efficacy data is available for both vaccines, noted the Ministry of Health. Trials have begun for both vaccines in children aged 12 and above, with the Pfizer-BioNTech dose achieving a 100 per cent efficacy rate in 2,260 adolescents aged 12 to 15. Similarly, Moderna has begun trials in 3,000 people aged 12 to 17, half of whom are getting two shots four weeks apart while … [Read more...] about Vaccinating children under 16: What are the safety concerns and is it necessary to do so?